Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of carvedilol in preventing heart failure following trastuzumab (Herceptin) therapy
IRCT2014112019840N1Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of carvedilol in breast cancer and heart failure (HF), sponsored by Tehran University of Medical Sciences. Started Sep 2014; status: completed.
02
Drugs
carvedilol
03
Conditions
breast cancerheart failure (HF)
Beyond the preview
Go deeper on IRCT2014112019840N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2014112019840N1.